| Recruiting | A Study of the TheraBionic P1 Device in Breast Cancer Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage IIIA | N/A | 2026-10-01 |
| Not Yet Recruiting | Ask Questions About Clinical Trials Oncology, Cardiac Disease, Neurologic Disorder | N/A | 2026-04-30 |
| Recruiting | Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma | N/A | 2026-04-01 |
| Not Yet Recruiting | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Advanced Breast Cancer | N/A | 2026-02-01 |
| Recruiting | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma Recurrent | N/A | 2025-10-20 |
| Recruiting | Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies Advanced Solid Tumor | Phase 1 | 2025-09-18 |
| Recruiting | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refr Metastatic Colorectal Adenocarcinoma | Phase 2 | 2025-09-10 |
| Recruiting | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. Ductal Carcinoma in Situ, Stage I Breast Cancer, Stage II Breast Cancer | N/A | 2025-08-18 |
| Recruiting | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fie Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2025-02-28 |
| Recruiting | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors Cancer, Cancer Survivors, Gastrointestinal Cancers | N/A | 2024-09-03 |
| Recruiting | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) Renal AL Amyloidosis | Phase 2 | 2024-07-11 |
| Recruiting | Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myelom Multiple Myeloma | Phase 2 | 2023-12-21 |
| Withdrawn | Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Can Locally Advanced Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma | N/A | 2023-07-25 |
| Recruiting | Dietary Reporting in the Amyloidoses Amyloidosis | N/A | 2023-03-02 |
| Recruiting | A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost D Healthy, Financial Toxicity | N/A | 2022-12-09 |
| Recruiting | F-Tryptophan PET/CT in Human Cancers Intracranial Glioma, Metastatic Brain Tumor, Breast Cancer | Phase 1 | 2022-09-29 |
| Withdrawn | Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant Relapsed Diffuse Large B-cell Lymphoma | Phase 2 | 2022-04-08 |
| Completed | Ask Questions (ASQ):Implementation of a Communication Intervention Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer | N/A | 2021-08-25 |
| Completed | COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia | Phase 2 | 2021-08-17 |
| Terminated | Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma Glioblastoma, Gliosarcoma | Phase 1 | 2021-08-12 |
| Active Not Recruiting | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements | Phase 2 | 2020-08-21 |
| Completed | DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Plasma Cell Myeloma | N/A | 2020-02-25 |
| Completed | Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care Malignant Neoplasm | N/A | 2020-01-16 |
| Terminated | ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | 2019-11-13 |
| Recruiting | C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience) Cancer Survivors | N/A | 2018-11-12 |
| Completed | Reducing Metabolic Syndrome Among Breast Cancer Survivors Breast Cancer | N/A | 2018-11-06 |
| Completed | Tobacco Cessation Intervention Smoking Tobacco | N/A | 2018-10-22 |
| Completed | Feasibility and Utilization of an Application-based Question Prompt List Financial Toxicity, Cancer, Question Prompt List | N/A | 2018-08-21 |
| Completed | AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm | Phase 2 | 2018-06-20 |
| Completed | Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate C Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone | Phase 2 | 2018-06-07 |
| Completed | Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7 | Phase 2 | 2018-04-24 |
| Completed | ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | 2018-03-08 |
| Completed | Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment Caregiver, Malignant Neoplasm | N/A | 2018-02-14 |
| Unknown | Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapse Recurrent Primary Amyloidosis | Phase 2 | 2017-08-25 |
| Active Not Recruiting | Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma | Phase 1 / Phase 2 | 2017-06-20 |
| Completed | Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Classical Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2016-06-01 |
| Completed | Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomog Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer | N/A | 2016-06-01 |
| Completed | Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent Recurrent Pleural Malignant Mesothelioma, Stage IV Pleural Mesothelioma | Phase 2 | 2016-03-15 |
| Completed | Low-Level Laser Therapy for Prevention of Oral Mucositis Mucositis | N/A | 2016-03-01 |
| Completed | BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer | Phase 1 / Phase 2 | 2015-12-01 |
| Withdrawn | EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma Adult Brain Glioblastoma, Adult Gliosarcoma, Recurrent Brain Neoplasm | Phase 1 / Phase 2 | 2015-08-01 |
| Completed | Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mas Adnexal Mass, Borderline Ovarian Epithelial Tumor, Ovarian Clear Cell Tumor | Phase 1 | 2015-08-01 |
| Withdrawn | Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Serous Tumor, Recurrent Fallopian Tube Carcinoma | Phase 1 | 2015-06-01 |
| Completed | PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prost Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma | Phase 1 | 2015-06-01 |
| Terminated | Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgki Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides | Phase 1 | 2015-02-12 |
| Completed | MK-3475 as Maintenance Therapy in Extensive Stage SCLC Extensive Stage Small Cell Lung Carcinoma | Phase 2 | 2015-02-01 |
| Recruiting | Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | N/A | 2014-08-01 |
| Completed | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer | Phase 1 | 2014-08-01 |
| Terminated | Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | N/A | 2014-06-01 |
| Completed | LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate C Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | 2014-05-01 |
| Terminated | Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Childhood Choroid Plexus Tumor, Childhood Medulloblastoma, Childhood Pineoblastoma | Phase 3 | 2013-08-01 |
| Terminated | First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD Light Chain Deposition Disease, Primary Systemic Amyloidosis | Phase 1 | 2013-03-01 |
| Completed | Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | N/A | 2013-03-01 |
| Completed | Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer Breast Cancer | N/A | 2012-10-01 |
| Withdrawn | Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Recep Breast Cancer Female | Phase 2 | 2012-06-01 |
| Terminated | Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia | Phase 1 | 2012-05-01 |
| Terminated | High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Tr Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | 2012-02-01 |
| Completed | Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | Phase 1 / Phase 2 | 2011-10-01 |
| Completed | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) Colorectal Cancer, Cancer of Pancreas, Pancreatic Neoplasm | Phase 1 | 2011-08-17 |
| Withdrawn | Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) Lung Cancer | Phase 1 | 2011-08-01 |
| Completed | Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma | N/A | 2011-07-01 |
| Unknown | Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Neuroblastoma | N/A | 2011-02-01 |
| Completed | Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Tre Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | Phase 2 | 2011-01-01 |
| Completed | Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT Hematological Malignancies | Phase 2 | 2010-11-01 |
| Terminated | Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation Multiple Myeloma | Phase 1 | 2010-11-01 |
| Completed | PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer Prostate Cancer | N/A | 2010-09-01 |
| Terminated | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Underg Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 2 | 2010-08-01 |
| Terminated | Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoin Breast Cancer | Phase 2 | 2010-07-01 |
| Terminated | Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastat Breast Cancer | Phase 2 | 2010-03-08 |
| Terminated | DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer Breast Cancer | Phase 1 | 2010-02-01 |
| Completed | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed A Prostate Cancer | Phase 2 | 2010-02-01 |
| Terminated | Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smolderi Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 2 | 2009-11-01 |
| Completed | Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers Prostate Cancer | — | 2009-11-01 |
| Completed | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | 2009-10-01 |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia | — | 2009-09-01 |
| Completed | Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectom Prostate Cancer | Phase 2 | 2009-08-01 |
| Withdrawn | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Ther Colorectal Cancer | Phase 1 | 2009-06-01 |
| Completed | Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Lary Head and Neck Cancer, Perioperative/Postoperative Complications, Precancerous Condition | Phase 1 | 2009-05-01 |
| Withdrawn | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Breast Cancer | Phase 1 | 2009-05-01 |
| Completed | Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2009-05-01 |
| Completed | Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules Pulmonary Nodule | Phase 1 | 2009-04-01 |
| Completed | Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis Lung Cancer, Metastatic Cancer | Phase 1 | 2009-03-01 |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hem Chronic Myeloproliferative Disorders, Leukemia, Lymphoma | Phase 2 | 2008-05-01 |
| Terminated | Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | — | 2008-04-01 |
| Completed | A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soy Healthy, no Evidence of Disease | N/A | 2008-04-01 |
| Terminated | Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer, Metastatic Cancer | Phase 2 | 2008-03-01 |
| Completed | Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2008-01-01 |
| Terminated | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer Breast Cancer | N/A | 2007-12-01 |
| Completed | Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docet Prostate Cancer | N/A | 2007-10-01 |
| Withdrawn | Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients Lymphoma | Phase 1 | 2007-10-01 |
| Completed | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Depositi Primary Systemic Amyloidosis, Light Chain Deposition Disease | Phase 2 | 2007-09-01 |
| Terminated | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With S Breast Cancer | Phase 2 | 2007-08-01 |
| Terminated | Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Ce Lung Cancer | Phase 2 | 2007-07-01 |
| Completed | Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Sta Mucositis, Multiple Myeloma | Phase 1 | 2007-06-01 |
| Completed | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer | Phase 2 | 2007-05-01 |
| Completed | Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite Malignant Mesothelioma, Pulmonary Complications | — | 2007-01-01 |
| No Longer Available | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | — | 2007-01-01 |
| Completed | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2006-11-01 |
| Terminated | Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small C Lung Cancer | Phase 2 | 2006-05-01 |
| Completed | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Pancreatic Cancer | — | 2006-02-01 |
| Completed | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer Kidney Cancer, Lung Cancer, Metastatic Cancer | Phase 2 | 2006-01-01 |
| Completed | Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery Lung Cancer, Metastatic Cancer | N/A | 2005-11-01 |
| Completed | Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage II Lung Cancer | Phase 2 | 2005-11-01 |
| Completed | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Ho Prostate Cancer | Phase 1 | 2005-08-01 |
| Withdrawn | Studying Umbilical Cord Blood From African-American Donors Health Status Unknown | — | 2005-08-01 |
| Completed | Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem C Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | 2005-07-01 |
| Completed | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patien Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | 2005-05-01 |
| Completed | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Canc Pancreatic Cancer | Phase 2 | 2005-05-01 |
| Withdrawn | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer Prostate Cancer | Phase 3 | 2005-05-01 |
| Completed | Identification of Biomarkers for Early Detection of Pancreatic Cancer Pancreatic Cancer | — | 2005-02-01 |
| Completed | Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2005-01-01 |
| Completed | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer Pancreatic Cancer | — | 2004-12-01 |
| Completed | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | N/A | 2004-10-01 |
| Completed | Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Esophageal Cancer, Gastric Cancer | Phase 2 | 2004-10-01 |
| Completed | Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors Breast Cancer, Obesity, Weight Changes | — | 2004-05-01 |
| Completed | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treati Lymphoma | Phase 1 | 2004-03-01 |
| Completed | Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer Breast Cancer | Phase 2 | 2004-02-01 |
| Completed | Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo Head and Neck Cancer | Phase 2 | 2003-12-01 |
| Completed | Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 2003-08-01 |
| Completed | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2003-06-01 |
| Completed | Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous L Leukemia | Phase 1 | 2003-06-01 |
| Completed | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Head and Neck Cancer, Lung Cancer | Phase 2 | 2003-06-01 |
| Completed | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer Prostate Cancer | Phase 2 | 2002-05-01 |
| Completed | Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Can Lung Cancer | Phase 2 | 2002-02-01 |
| Withdrawn | Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2002-02-01 |
| Completed | XK469 in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2002-01-01 |
| Completed | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2002-01-01 |
| Completed | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocar Prostate Cancer | Phase 2 | 2001-11-01 |
| Completed | Biological Therapy in Treating Women With Stage IV Breast Cancer Breast Cancer | Phase 1 | 2001-10-01 |
| Completed | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2001-10-01 |
| Completed | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2001-10-01 |
| Completed | Proteases in Patients With Prostate Cancer That Has Spread to the Bone Anemia, Metastatic Cancer, Myelodysplastic Syndromes | — | 2001-07-01 |
| Completed | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2001-03-01 |
| Completed | PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma Intraocular Melanoma, Melanoma (Skin) | Phase 2 | 2001-01-01 |
| Completed | Chemotherapy in Treating Patients With Advanced Kidney Cancer Kidney Cancer | Phase 2 | 2000-12-01 |
| Completed | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer Kidney Cancer | Phase 2 | 2000-06-01 |
| Completed | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-05-01 |
| Completed | Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease Lymphoma | Phase 2 | 1999-06-01 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Remo Pancreatic Cancer | Phase 2 | 1999-04-01 |
| Completed | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Prostate Cancer | Phase 2 | 1998-10-01 |
| Completed | Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleuk Brain and Central Nervous System Tumors | Phase 2 | 1998-08-01 |
| Completed | Fenretinide in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-05-01 |
| Completed | Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome Leukemia, Myelodysplastic Syndromes | Phase 2 | 1998-05-01 |
| Completed | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia Leukemia | Phase 1 | 1998-05-01 |
| Completed | Combination Chemotherapy In Treating Patients With Advanced Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-05-01 |
| Completed | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 1998-02-01 |
| Completed | Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astr Brain and Central Nervous System Tumors | Phase 2 | 1997-06-01 |
| Completed | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma Melanoma (Skin) | Phase 2 | 1997-06-01 |
| Completed | KRN5500 in Treating Patients With Metastatic Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1997-05-01 |
| Completed | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 1997-01-01 |
| Completed | Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Leukemia, Lymphoma | Phase 2 | 1996-12-01 |
| Completed | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1995-10-01 |
| Completed | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 1994-02-01 |
| Completed | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hod Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 1993-10-01 |
| Completed | Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplast Leukemia, Myelodysplastic Syndromes | Phase 2 | 1987-08-01 |
| Withdrawn | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung C Non-small Cell Lung Cancer | Phase 1 / Phase 2 | — |